References
- American Society of Reproductive Medicine, 2007. Financial Compensation of Oocyte Donors. Fertility and Sterility, 88.2, pp.305–309.
- Bagheri, A., 2006. Compensated Kidney Exchange: A Review of the Iranian Model. Kennedy Institute of Ethics Journal, 16.3, pp.269–82.
- Baylis, F., 2009. For Love or Money? The Saga of Korean Women who Provided Eggs for Embryonic Stem Cell Research. Theoretical Medicine and Bioethics, New England Journal of Medicine, 30, pp.185–96.
- Baylis, F., and C. McLeod, 2007. The Stem Cell Debate Continues: The Buying and Selling of Eggs for Research. Journal of Medical Ethics, 33, pp.726–31.
- Braun, K., J. Sandor, and S. Schultz, 2011. Oocytes for Research: Between Commercialization and Antipayment Provisions. The Case of Spain and the European Framework. 18 April. Paper presented at the EC REMEDIE project closing conference, Bilbao.
- Caulfield, T., T. Scott, I. Hyun, R. Lovell-Badfe, K. Kato, and A. Zarzeczny, 2010. Stem Cell Research Policy and iPS Cells. Nature Methods, 7, pp.28–33.
- Crimaldi, L., 2009. Stalled Economy Fertile Ground for Baby Business. Boston Herald, 25 January.
- Cyranoski, D., 2004. Korea’s Stem-cell Stars Dogged by Suspicion of Ethical Breach. The Global Body Market: Altruism’s Limits, 429, pp.3.
- Daley, G.Q., and J.H. Solbakk, 2011. Stem Cells: Triple Genomes Go Far. Nature, 478, pp.40–41.
- Darnovsky, M., 2008. Eggs, Wombs and the Economy: Hard Times Fuel a Buyer’s Market. 8 December. Available at http://www.biopoliticaltimes.org/article.php?id=4427.
- Dickenson, D., 2002. Commodification of Human Tissue: Implications for Feminist and Development Ethics. Developing World Bioethics, 2, pp.55–63.
- Dickenson, D., 2004. The Threatened Trade in Human Ova. The Global Body Market: Altruism’s Limits, 5.2, pp. 86.
- Dickenson, D., 2006. The Lady Vanishes: What’s Missing from the Stem Cell Debate. Journal of Bioethical Inquiry, 3, pp.43–54.
- Dickenson, D., 2009a. Good Science and Good Ethics: Why We Should Discourage Payment for Eggs in Stem Cell Research. The Global Body Market: Altruism’s Limits, 10.11, pp. 743.
- Dickenson, D., 2009b. Body Shopping: Converting Body Parts to Profit. Oxford: Oneworld.
- Dickenson, D., 2013a. Exploitation and Choice in the Global Egg Trade: Emotive Terminology or Necessary Critique? In Michele Goodwin, ed., Regulating Contestable Commodities in the Global Body Market: Altruism’s Limits. New York: Cambridge University Press, pp.21–43.
- Dickenson, D., 2013 b. Me Medicine vs. We Medicine: Reclaiming Biotechnology for the Common Good. New York: Columbia University Press.
- Dickenson, D., and I. Alkorta, 2008. Ova Donation for Research: An International Comparative Perspective. International Journal of Feminist Approaches to Bioethics, 1, pp.125–44.
- Dodds, S., 2003. Women, Commodification and Stem-cell Research. In J. Humber, and R.F. Almeder, eds., Biomedical Ethics Reviews: Stem Cell Research. Totowa, NJ: Humana Press, pp.149–75.
- Editorial: High-interest Clones. 2011. Nature, 478, pp. 5.
- Egli, D., A.E. Chen, G. Saphier, D. Powers, M. Alper, K. Katz, et al., 2011. Impracticality of Egg Donor Recruitment in the Absence of Compensation. The Global Body Market: Altruism’s Limits, (7 October), 9 (4) pp.293–4.
- Empire State Stem Cell Board, 2009. Statement of the Empire State Stem Cell Board on the Compensation of Oocyte Donors. Available at: http://stemcell.ny.gov/docs/esscb-statement-compensation-oocyte-donors.
- Goodwin, M.B., ed., 2010. Baby Markets: Money and the New Politics of Creating Families. New York: Cambridge University Press.
- Heijnen, E., M. Eikemans, and C. de Clerk, et al., 2007. A Mild Treatment Strategy for IVF: A Randomised Non-Inferiority Trial. Lancet, 369, pp.743–49.
- HFEA Statement on Donating Eggs for Research, 21 February 2007. Available at: http://www.hfea.gov.uk/471.html.
- Hwang, W.S., et al., 2004. Evidence of a Pluripotent Human Stem Cell Line Derived from a Cloned Blastocyst. Science, 303, pp.1669–74.
- Hwang, W.S., 2005. Patient-specific Embryonic Stem Cell Lines Derived from Human SCNT Blastocysts. Science, 308, pp.1777–83.
- Hyun, I., 2008. Stem Cells from Skin Cells: The Ethical Questions. Hastings Center Report, 38.1, pp.20–22.
- Hyun, I., 2011. Moving Human SCNT Research Forward Ethically. Cell Stem Cell, 9.4, pp.295–97.
- Hyun, I., and P. Tesar, 2011. Stem Cell: Cloning Advance Calls for Careful Regulation. Nature, 478, pp.36–37.
- International Society for Stem Cell Research, 2006. Guidelines for the conduct of human embryonic stem cell research. Available at: http://isscr.org/home/publications/guide-clintrans
- Jayaprakasan, K., M. Herbert, E. Moody, J. Stewart, and A.P. Murdoch, 2007. Estimating the Risks of Ovarian Hyperstimulation Syndrome (OHSS): Implications for Egg Donation for Research. Human Fertility, 10.3, pp.183–87.
- Johnston, J., 2006. Paying Egg Donors: Exploring the Arguments. Hastings Center Report, 36.1, pp.28–31.
- Kramer, W., J. Schneider, and N. Schultz, 2009. US Oocyte Donors: A Retrospective Study of Medical and Psychosocial Issues. Human Reproduction, 24.12, pp.3144–3149.
- Magnus, D., and M.K. Cho, 2005. Issues in Oocyte Donation for Stem Cell Research. Science, 308, pp.1747–48.
- Marx, K., 1867 (1954). Capital. Trans. Samuel Moore and Edward Aveling, ed. Friedrich Engels. Moscow: Progress.
- McLeod, C., and F. Baylis, 2006. Feminists on the Inalienability of Human Embryos. Hypatia, 21.1, pp.1–24.
- Moazam, F., R. Zaman, and A. Jafarey, 2009. Conversations with Kidney Vendors in Pakistan: An Ethnographic Study. Hastings Center Report, 39.3, pp.29–44.
- Noggle, S., H.L. Fung, A. Gore, H. Martinez, K.C. Satriani, R. Prosser, K. Oum, et al, 2011. Human Oocytes Reprogram Somatic Cells to a Pluripotent State. Nature, 478, pp.70–75.
- Norsigian, J., 2005. Egg Donation for IVF and Stem Cell Research: Time to Weigh the Risks to Women’s Health. Available at: http://www.ourbodiesourselves/orgbook/companionasp?id=3197&page=2.
- Paik, Y.G., 2006. Beyond Bioethics: The Globalized Reality of Ova Trafficking and the Possibility of Feminist Intervention. Paper presented at the International Forum on the Human Rights of Women and Biotechnology, Seoul, 21 September.
- Pateman, C., 1988. The Sexual Contract. Cambridge: Polity Press.
- Pauli, D., V. Emmanuele, K.N. Weiss, N. Treff, L. Stewart, H. Hua, et al., 2012. Nuclear Genome Transfer in Human Oocytes Eliminates Mitochondrial DNA Variants. Nature, 19 December. doi:10.1038/nature11800.
- Reynolds, J., 2009. New York: OK to Pay for Eggs for Stem Cell Research. Biopolitical Times, 19 June. Available at: http://www.biopoliticaltimes.org/article.php?id=4684.
- Ryan, A., 1987. Exploitation. In David Miller et al., eds., The Blackwell Encyclopaedia of Political Thought, Oxford: Blackwell, pp.143–44.
- Sample, I., 2013. Three-person IVF: government backs mitochondrial transfer. Guardian, 28 June. Available at: http://www.theguardian.com/science/2013/jun/28/uk-government-ivf-dna-three-people.
- Schepher-Hughes, N., and Tober, D., 2013. Risks are many in paying women to donate eggs. Sacramento Bee, 16 July. Available at: http://www.sacbee.com/2013/07/16/5568944/risks-are-many-in-paying-women.html#storylink=cpy.
- Shanks, P., 2011. A Campaign to Allow a Market in Women’s Eggs for a New Kind of Cloning Research. Biopolitical Times, 7 October. Available at: http://www.geneticsandsociety.org/article.php?id=5882.
- Shanks, P., 2012. A New Push for Human Cloning in Korea. Biopolitical Times, 20 January. Available at: http://www.geneticsandsociety.org/article.php?id=6038.
- Smart, N., S. Bollini, K.N. Dubé, J.M. Vieira, B. Zhou, S. Davidson, D. Yellon, et al., 2011. De Novo Cardiomycytes from within the Activated Adult Heart after Injury. Nature, 474, pp.640–44.
- Spar, D., 2006. The Baby Business: How Money, Science, and Politics Drive the Commerce of Conception. Cambridge, MA: Harvard University Press.
- Spar, D., 2007. The Egg Trade: Making Sense of the Market for Human Oocytes. NEJM, 356.13, pp.1289–91.
- Steinbock, B., 2004. Payment for Egg Donation and Surrogacy. Mt Sinai Journal of Medicine, 71.4, pp.55–65.
- Tachibana, M., P. Amato, M. Sparman, J. Woodward, D.M. Sanchis, H. Ma, et al, 2012. Towards Germline Gene Therapy of Inherited Mitochondrial Diseases. Nature, 493, pp.627–31.
- Takahashi, K., K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka, 2007. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell, 131.5, pp.861–72.
- Wade, N., 2011. After Setbacks in Harvesting Stem Cells, a New Approach Shows Promise. New York Times, 5 October. Available at: http://www.nytimes.com/2011/10/06/science/06stem.html.
- Waldby, C., 2008. Oocyte Markets: Women’s Reproductive Work in Embryonic Stem Cell Research. New Genetics and Society, 27.1: pp.19–31.
- Waldby, C., and K. Carroll, 2012. Egg Donation for Stem Cell Research: Ideas of Surplus and Deficit in Australian IVF Patients’ and Reproductive Donors’ Accounts. Sociology of Health and Illness, 34.4, pp.513–28.
- Waldby, C., and M. Cooper, 2010. From Reproductive Work to Regenerative Labour: The Female Body and the Stem Cell Industries. Feminist Theory, 11.1, pp.3–22.
- Wood, S., R. Jimenez, and J.W. Lee, 2009. Dramatic Changes in Stem Cell Funding by the California Institute of Regenerative Medicine (CIRM): Implications for the Future of Stem Cell Research. Poster presented at the seventh annual convention of the International Society for Stem Cell Research, Barcelona, 10 July.